ENLV Stock Latest News
Company AnnouncementsEnlivex Reaches 70% Enrollment in Phase 2b Allocetra Trial for Knee Osteoarthritis4d ago6KENLV
Company AnnouncementsEnlivex Faces Nasdaq Delisting, Launches Appeal and 1-for-16 Reverse Split5d ago6KENLV
Company AnnouncementsEnlivex to Implement 1-for-16 Reverse Share Split Effective October 27, 20261w ago6KENLVCompany AnnouncementsEnlivex Slashes Costs and Workforce to Prioritize Phase 2b Knee Osteoarthritis Trial1w ago6KENLV
The FlyEnlivex Therapeutics to reduce workforce by 60%1w agoENLV
Company AnnouncementsEnlivex Calls October 14 Extraordinary Meeting to Approve 1-for-16 Reverse Share Split1M ago6KENLV
Company AnnouncementsEnlivex Posts Massive H1 2026 Profit on Surging Digital Asset Holdings1M ago6KENLV
Company AnnouncementsEnlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement1M ago6KENLV
Company AnnouncementsEnlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million3M ago6KENLV
Company AnnouncementsEnlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone3M ago6KENLV
Company AnnouncementsEnlivex Strikes $400 Million Private Placement Tied to RAIN Token Treasury Strategy3M ago6KENLV
Company AnnouncementsEnlivex Secures $400 Million Premium-Priced Private Placement Backed by RAIN Tokens3M ago6KENLVCompany AnnouncementsEnlivex Reveals $1.1 Billion RAIN Token Treasury and $66.16 NAV Per Share3M ago6KENLV
Company AnnouncementsEnlivex Wins FDA RMAT Status for Allocetra in Age-Related Knee Osteoarthritis3M ago6KENLV